SafeHeal has developed Colovac, a colorectal anastomosis protection device that minimizes fecal contact at the anastomotic site after surgery. This technology aims to reduce the risk of anastomotic leaks, potentially eliminating the need for diverting ostomies in patients undergoing colectomy.
Funding
$52.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Following colorectal surgery, the risk of anastomotic leaks at the surgical site poses a significant threat to patient recovery. Current surgical procedures often require a diverting ostomy to minimize fecal contact with the anastomosis, but this can lead to additional complications and a reduced quality of life for patients.
Solution
SafeHeal's Colovac is a colorectal anastomosis protection device designed to minimize fecal contact at the surgical site following colectomy. The device aims to reduce the incidence of anastomotic leaks, potentially eliminating the need for a diverting ostomy. By protecting the anastomosis during the critical healing period, Colovac allows patients to maintain natural digestive function and avoid the burden and complications associated with stoma care. The device is designed to be minimally invasive and fully reversible.
Target Audience
The primary target audience includes colorectal surgeons and patients undergoing colectomy who are at risk of developing anastomotic leaks.
Features
- Endoluminal bypass sheath designed to divert fecal content away from the anastomosis
- Minimally invasive insertion and removal
- Designed to be fully reversible at any time
- Aims to reduce the risk of anastomotic leaks
- Intended to eliminate the need for diverting ostomies